EA201892822A1 - Новые антибактериальные соединения - Google Patents

Новые антибактериальные соединения

Info

Publication number
EA201892822A1
EA201892822A1 EA201892822A EA201892822A EA201892822A1 EA 201892822 A1 EA201892822 A1 EA 201892822A1 EA 201892822 A EA201892822 A EA 201892822A EA 201892822 A EA201892822 A EA 201892822A EA 201892822 A1 EA201892822 A1 EA 201892822A1
Authority
EA
Eurasian Patent Office
Prior art keywords
connections
new antibacterial
new
antibacterial
pharmaceutical compositions
Prior art date
Application number
EA201892822A
Other languages
English (en)
Inventor
Розелла Омбрато
Габриеле Магаро'
Барбара Гарофало
Гвидо Фурлотти
Джорджина Мангано
Алессандра Капеццоне Де Йоаннон
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Publication of EA201892822A1 publication Critical patent/EA201892822A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Настоящее изобретение относится к новым антибактериальным соединениям, содержащим их фармацевтическим композициям и их применению в качестве противомикробных средств.
EA201892822A 2016-06-08 2017-06-05 Новые антибактериальные соединения EA201892822A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16173550 2016-06-08
PCT/EP2017/063600 WO2017211759A1 (en) 2016-06-08 2017-06-05 New antibacterial compounds

Publications (1)

Publication Number Publication Date
EA201892822A1 true EA201892822A1 (ru) 2019-06-28

Family

ID=56116327

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201892822A EA201892822A1 (ru) 2016-06-08 2017-06-05 Новые антибактериальные соединения
EA201892815A EA201892815A1 (ru) 2016-06-08 2017-06-05 Новые антибактериальные соединения

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201892815A EA201892815A1 (ru) 2016-06-08 2017-06-05 Новые антибактериальные соединения

Country Status (27)

Country Link
US (2) US10640488B2 (ru)
EP (2) EP3468970A1 (ru)
JP (2) JP2019517545A (ru)
KR (2) KR20190019084A (ru)
CN (2) CN109415373A (ru)
AR (2) AR108777A1 (ru)
AU (2) AU2017276627A1 (ru)
BR (2) BR112018075297A2 (ru)
CA (2) CA3025624A1 (ru)
CY (1) CY1123194T1 (ru)
DK (1) DK3468975T3 (ru)
EA (2) EA201892822A1 (ru)
ES (1) ES2802233T3 (ru)
HR (1) HRP20200894T1 (ru)
HU (1) HUE049547T2 (ru)
IL (2) IL263285A (ru)
LT (1) LT3468975T (ru)
MA (1) MA45221A (ru)
MD (1) MD3468975T2 (ru)
ME (1) ME03738B (ru)
MX (2) MX2018015125A (ru)
PL (1) PL3468975T3 (ru)
PT (1) PT3468975T (ru)
RS (1) RS60511B1 (ru)
SG (2) SG11201810352XA (ru)
SI (1) SI3468975T1 (ru)
WO (2) WO2017211760A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201810352XA (en) * 2016-06-08 2018-12-28 Acraf New antibacterial compounds
US11976084B2 (en) 2020-11-23 2024-05-07 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11970502B2 (en) 2021-05-04 2024-04-30 Enanta Pharmaceuticals, Inc. Macrocyclic antiviral agents
CN113698412A (zh) * 2021-09-01 2021-11-26 临沂大学 一种香豆素并[4,3-b]吡咯类衍生物及其合成方法和应用
US11919910B2 (en) 2021-11-12 2024-03-05 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
WO2023086350A1 (en) 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Alkyne-containing antiviral agents
WO2023086352A1 (en) 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
US11993600B2 (en) 2021-12-08 2024-05-28 Enanta Pharmaceuticals, Inc. Saturated spirocyclics as antiviral agents
US12006291B2 (en) 2022-01-11 2024-06-11 Enanta Pharmaceuticals, Inc. Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid
CN115850672B (zh) * 2022-11-25 2024-07-19 浙江甬仑聚嘉新材料有限公司 一种液晶聚合物及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2886570B2 (ja) * 1989-09-29 1999-04-26 エーザイ株式会社 縮合ヘテロ環を有する化合物
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
US5607936A (en) 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
FR2822154B1 (fr) 2001-03-13 2005-10-21 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
CA2488635C (en) * 2002-06-12 2012-10-23 Abbott Laboratories Antagonists of melanin concentrating hormone receptor
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2006046552A1 (ja) * 2004-10-27 2006-05-04 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
MX2007012234A (es) 2005-03-31 2008-03-18 Johnson & Johnson Compuestos de pirazol biciclico como agentes antibacterianos.
CN101258157A (zh) * 2005-05-24 2008-09-03 阿斯利康(瑞典)有限公司 具有抗菌活性的氨基哌啶喹啉及其氮杂等构类似物
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (ja) * 2005-06-24 2014-01-29 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
CN101346379A (zh) * 2005-10-21 2009-01-14 葛兰素集团有限公司 用作抗菌剂的周环并合的三环化合物
KR20090130347A (ko) * 2007-05-09 2009-12-22 화이자 인코포레이티드 치환된 헤테로사이클릭 유도체 및 조성물 및 항균제로서의 이의 약학적 용도
JP5620636B2 (ja) * 2007-11-26 2014-11-05 富山化学工業株式会社 新規な複素環化合物またはその塩を含有する抗菌剤
US20110071155A1 (en) * 2008-05-23 2011-03-24 Carlos Alemparte-Gallardo Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials
CA2725726A1 (en) 2008-05-23 2009-11-26 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
TW201022279A (en) * 2008-11-14 2010-06-16 Astrazeneca Ab Chemical compounds
JP5653935B2 (ja) * 2009-01-15 2015-01-14 グラクソ グループ リミテッドGlaxo Group Limited 抗菌薬として有用なナフチリジン―2(1h)−オン化合物
CA2750047A1 (en) 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
US9156822B2 (en) 2010-07-02 2015-10-13 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine D2 receptors
WO2012117421A1 (en) * 2011-03-02 2012-09-07 Orchid Research Laboratories Ltd Histone deacetylase inhibitors
AU2012275499A1 (en) * 2011-06-27 2013-12-19 Kyorin Pharmaceutical Co., Ltd. Bridged bicyclic compounds for the treatment of bacterial infections
BR112014011064A8 (pt) 2011-11-08 2017-12-26 Actelion Pharmaceuticals Ltd derivados de antibióticos 2-oxo-oxazolidin-3,5-diila
JP2014533747A (ja) 2011-11-30 2014-12-15 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 3,7−二置換オクタヒドロ−2H−ピリド[4,3−e][1,3]オキサジン−2−オン抗生物質
CN105218501A (zh) * 2014-07-03 2016-01-06 南京大学 含哌嗪环的香豆素类衍生物及其制备与在抗菌药物中的应用
KR20170043603A (ko) 2014-08-22 2017-04-21 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 네이세리아 고노레아에 감염을 치료하기 위한 트리시클릭 질소 함유 화합물
MA41168A (fr) * 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
SG11201810352XA (en) * 2016-06-08 2018-12-28 Acraf New antibacterial compounds

Also Published As

Publication number Publication date
LT3468975T (lt) 2020-08-10
IL263283A (en) 2018-12-31
SG11201810389XA (en) 2018-12-28
US20200095225A9 (en) 2020-03-26
MD3468975T2 (ro) 2020-08-31
IL263285A (en) 2018-12-31
PT3468975T (pt) 2020-06-23
US20190161472A1 (en) 2019-05-30
SI3468975T1 (sl) 2020-08-31
ME03738B (me) 2021-01-20
CY1123194T1 (el) 2021-10-29
BR112018075297A2 (pt) 2019-03-19
EA201892815A1 (ru) 2019-05-31
CN109415373A (zh) 2019-03-01
BR112018075334A2 (pt) 2019-03-19
JP2019517545A (ja) 2019-06-24
AR108778A1 (es) 2018-09-26
DK3468975T3 (da) 2020-07-13
EP3468970A1 (en) 2019-04-17
CA3025624A1 (en) 2017-12-14
EP3468975A1 (en) 2019-04-17
WO2017211759A1 (en) 2017-12-14
US20190256495A1 (en) 2019-08-22
AU2017276627A1 (en) 2018-12-20
MA45221A (fr) 2021-05-19
KR20190019084A (ko) 2019-02-26
HRP20200894T1 (hr) 2020-09-18
MX2018015125A (es) 2019-09-02
US10633366B2 (en) 2020-04-28
WO2017211760A1 (en) 2017-12-14
US10640488B2 (en) 2020-05-05
HUE049547T2 (hu) 2020-10-28
CA3025270A1 (en) 2017-12-14
JP2019517546A (ja) 2019-06-24
MX2018015126A (es) 2019-09-02
EP3468975B1 (en) 2020-04-01
AR108777A1 (es) 2018-09-26
KR20190019083A (ko) 2019-02-26
SG11201810352XA (en) 2018-12-28
PL3468975T3 (pl) 2020-09-07
RS60511B1 (sr) 2020-08-31
AU2017276626A1 (en) 2018-12-20
ES2802233T3 (es) 2021-01-18
CN109790157A (zh) 2019-05-21

Similar Documents

Publication Publication Date Title
EA201892822A1 (ru) Новые антибактериальные соединения
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MD3464249T2 (ro) Derivați carbonucleozidici substituiţi utili în calitate de agenți anticanceroşi
EA201890858A1 (ru) 2,4-дигидроксиникотинамиды как агонисты apj
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201890052A1 (ru) Регуляторы nrf2
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
CY1123465T1 (el) Αντιβακτηριακες ενωσεις ευρεως φασματος
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201790184A1 (ru) Пестицидные композиции
EA201692525A1 (ru) Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов
EA201790570A1 (ru) Модуляторы р2х7
EA201891644A1 (ru) Антибактериальные соединения и их применение
MX2017007377A (es) Compuestos organicos.
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201791174A1 (ru) Антимикотическое соединение
EA201792262A1 (ru) Пироглутамат вортиоксетина
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
EA201892203A1 (ru) Оксабороловые сложные эфиры, их применение
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
MA44601A (fr) Composition ophtalmique contenant de la pvp-i
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
EA201991655A1 (ru) Тиобензоимидазолы в качестве фунгицидов